Department of Rehabilitation Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand,
Lung. 2013 Oct;191(5):531-6. doi: 10.1007/s00408-013-9492-2. Epub 2013 Jul 23.
Although β blockade (BB) in patients with chronic obstructive pulmonary disease (COPD) does not show signs of worsening pulmonary function or respiratory symptoms, the effects on cardiopulmonary exercise testing (CPET) remain unclear. The aim of this study was to determine whether BB affects exercise capacity, gas exchange, and hemodynamic responses in patients with COPD.
Twenty-four COPD subjects on BB were matched to 24 COPD subjects without BB according to age, gender, body mass index, and severity of COPD. All subjects underwent resting pulmonary function and symptom-limited CPET.
Comparing COPD patients with and without BB revealed that percent peak oxygen consumption and VE/VCO2 nadir were not significantly different (45 ± 16 vs. 51 ± 23 %, p = 0.30, and 35.1 ± 8.5 vs. 36.2 ± 11.6 %, p = 0.69). Systolic blood pressure and heart rate at peak exercise were significantly decreased in COPD patients with BB (168 ± 16 vs. 185 ± 20 mmHg, and 109 ± 16 vs. 122 ± 14 bpm, respectively, p < 0.05).
Exercise capacity and gas exchange remain unaffected in patients with COPD in the presence of BB, although heart rate and blood pressure are lower. These findings imply that BB does not adversely affect functional capacity in patients with COPD.
尽管β受体阻滞剂(BB)在慢性阻塞性肺疾病(COPD)患者中没有显示出肺功能恶化或呼吸道症状加重的迹象,但对心肺运动测试(CPET)的影响仍不清楚。本研究旨在确定 BB 是否会影响 COPD 患者的运动能力、气体交换和血液动力学反应。
根据年龄、性别、体重指数和 COPD 严重程度,将 24 名接受 BB 治疗的 COPD 患者与 24 名未接受 BB 治疗的 COPD 患者相匹配。所有患者均进行静息肺功能和症状限制的 CPET。
比较有和没有 BB 的 COPD 患者发现,峰值摄氧量百分比和 VE/VCO2 最低点没有显著差异(45±16%与 51±23%,p=0.30,和 35.1±8.5%与 36.2±11.6%,p=0.69)。接受 BB 的 COPD 患者在峰值运动时的收缩压和心率显著降低(168±16 与 185±20mmHg,和 109±16 与 122±14bpm,分别,p<0.05)。
在存在 BB 的情况下,COPD 患者的运动能力和气体交换仍然不受影响,尽管心率和血压较低。这些发现表明 BB 不会对 COPD 患者的功能能力产生不利影响。